drugset / Trial / NCT00057707

Effects of Modafinil on Brain Function in Patients With Schizophrenia

NCT00057707

Phase 1 Completed 176 enrolled National Institute of Mental Health (NIMH)
RandomizedCrossoverOther

Summary

This study will evaluate whether modafinil improves cognition in patients with schizophrenia and healthy volunteers. Modafinil is a drug that has been FDA approved for day-time sleepiness and allegedly increase the amount of the neurotransmitter dopamine in the frontal cortex of the brain ...

Timeline

Start
2003-03-26
Primary completion
2017-06-16
Completion
2017-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule